6
Clinical Trials associated with SR-1375一项在成人社区获得性肺炎住院患者中评价SR1375的有效性和安全性的随机、双盲、安慰剂平行对照的Ⅱ期临床研究
[Translation] A randomized, double-blind, placebo-controlled phase II clinical study to evaluate the efficacy and safety of SR1375 in adult patients hospitalized with community-acquired pneumonia
评估SR1375治疗肺炎患者的有效性和SR1375剂量效应关系
[Translation] To evaluate the efficacy of SR1375 in the treatment of pneumonia patients and the dose-effect relationship of SR1375
/ Not yet recruitingPhase 2 A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of SR1375 in Hospitalized Adult Patients With Community-acquired Pneumonia
This is a phase 2 study to evaluate the efficacy and safety of SR1375 in hospitalized adult patients with CAP. Patients will receive SR1375 or placebo for 8 weeks. The study duration for each patient is up to 10 weeks.
A Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of SR1375 in Hospitalized Patients With Pneumonia
Start Date19 Jan 2023 |
Sponsor / Collaborator- |
100 Clinical Results associated with SR-1375
100 Translational Medicine associated with SR-1375
100 Patents (Medical) associated with SR-1375
100 Deals associated with SR-1375